The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsulinism and Postpancreatectomy Diabetes: A Pilot Study
Arpana Rayannavar, Lauren M Mitteer, Courtney A Balliro, Firas H El-Khatib, Katherine L Lord, Colin P Hawkes, Lance S Ballester, Edward R Damiano, Steven J Russell, Diva D De León, Arpana Rayannavar, Lauren M Mitteer, Courtney A Balliro, Firas H El-Khatib, Katherine L Lord, Colin P Hawkes, Lance S Ballester, Edward R Damiano, Steven J Russell, Diva D De León
Abstract
Objective: To determine whether the bihormonal bionic pancreas (BHBP) improves glycemic control and reduces hypoglycemia in individuals with congenital hyperinsulinism (HI) and postpancreatectomy diabetes (PPD) compared with usual care (UC).
Research design and methods: Ten subjects with HI and PPD completed this open-label, crossover pilot study. Coprimary outcomes were mean glucose concentration and time with continuous glucose monitoring (CGM) glucose concentration <3.3 mmol/L.
Results: Mean (SD) CGM glucose concentration was 8.3 (0.7) mmol/L in the BHBP period versus 9 (1.8) mmol/L in the UC period (P = 0.13). Mean (SD) time with CGM glucose concentration <3.3 mmol/L was 0% (0.002) in the BHBP period vs. 1.3% (0.018) in the UC period (P = 0.11).
Conclusions: Relative to UC, the BHBP resulted in comparable glycemic control in our population.
Trial registration: ClinicalTrials.gov NCT03303196.
© 2021 by the American Diabetes Association.
Figures
References
- Lord K, Dzata E, Snider KE, Gallagher PR, De León DD. Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases. J Clin Endocrinol Metab 2013;98:E1786–E1789
- Arya VB, Senniappan S, Demirbilek H, et al. . Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS One 2014;9:e98054.
- Beltrand J, Caquard M, Arnoux JB, et al. . Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care 2012;35:198–203
- Welters A, Meissner T, Grulich-Henn J, et al. . Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism. Orphanet J Rare Dis 2018;13:230.
- Russell SJ, El-Khatib FH, Sinha M, et al. . Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371:313–325
- El-Khatib FH, Russell SJ, Magyar KL, et al. . Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 2014;99:1701–1711
- El-Khatib FH, Balliro C, Hillard MA, et al. . Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet 2017;389:369–380
- Russell SJ, Hillard MA, Balliro C, et al. . Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol 2016;4:233–243
Source: PubMed